GLAXOSMITHKLINE FINANCE PLC

Company number

00242686

Status

Active

Incorporation

1929-10-02

Last accounts made up

2024-12-31

Account category

FULL

Primary SIC

64999

Hubs

UK Fintech

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Deloitte LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Having assessed the principal risks of the Company and other matters, the Directors are of the opinion that the current level of activity remains sustainable. The Directors in their considerations have included the accessibility of additional capital and the potential risk to liquidity. The Directors have considered the Company's ability to continue as a going concern for a minimum of twelve months from the date of signing of these financial statements. The Directors have taken into account that as part of the Group, the Company has the support from the Group through the access to the Group cash pooling mechanism and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”

Subsidiaries

• 14245563 CANADA INC. · 100% held · Canada
• 14934792 Canada Inc. · 100% held · Canada
• Action Potential Venture Capital Limited · 100% held · United Kingdom
• Bellus Health Inc · 71.03% held · Canada
• GlaxoSmithKline Finance plc · United Kingdom · investment holding company, as well as to provide financial services to other companies within the Group, including borrowing through the issue of short-term securities and investing in short-term securities in order to manage the liquidity requirements of Group undertakings.

Significant events

• “IFRS 18 Presentation and disclosure in financial statements: The standard was issued by the IASB on 9 April 2024 and introduces new presentation and disclosure requirements. The Company is assessing the impact of adopting the new requirements introduced by IFRS 18, and will adopt the standard for the reporting period ending 31 December 2027, subject to endorsement in the UK.”

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers